Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma - PubMed (original) (raw)
Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma
Hitoe Torisu-Itakura et al. Clin Cancer Res. 2007.
Abstract
Purpose: Identification of regional node metastasis is important for accurate staging and optimal treatment of early melanoma. We hypothesize that the nodal profile of immunoregulatory cytokines can confirm the identity of the first tumor-draining regional node, i.e., the sentinel node (SN) and indicate its tumor status.
Experimental design: RNA was extracted from freshly dissected and preserved nodal tissue of 13 tumor-negative SNs, 10 tumor-positive SNs (micrometastases <2 mm), and 11 tumor-negative non-SNs (NSN). RNA was converted into cDNA and then amplified by PCR. Expression of 96 cytokines and chemokines was assessed using cDNA microarray and compared by using hierarchical clustering.
Results: Fifty-seven genes were expressed at significantly (P < 0.05) different levels in SNs and NSNs (4 genes had higher expression, and 53 genes had lower expression in SNs). Expression levels of interleukin-13 (IL-13), leptin, lymphotoxin beta receptor (LTbR), and macrophage inflammatory protein 1b (MIP1b) were significantly higher (P < 0.04, P < 0.01, P < 0.05, and P < 0.01, respectively), and expression level of IL-11Ra was lower (P < 0.03) for tumor-positive as compared with tumor-negative SN. Receiver-operator characteristics curve analyses showed that the area under the curve (AUC) for IL-13, leptin, LTbR, MIP1b, and IL-11Ra was 0.79, 0.83, 0.75, 0.81, and 0.77, respectively. The AUC for the five genes in combination was 0.973, suggesting high concordance of gene-expression profiles with SN staging.
Conclusions: SNs have a different immunoregulatory cytokine profile than NSNs. The cytokine profile of tumor-positive SNs; increased expression of IL-13, leptin, LTbR, and MIP1b and decreased expression of IL-11Ra, may provide clues to the local tumor lymph node interaction seen in the earliest steps of melanoma metastasis.
Similar articles
- Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
Lee JH, Torisu-Itakara H, Cochran AJ, Kadison A, Huynh Y, Morton DL, Essner R. Lee JH, et al. Clin Cancer Res. 2005 Jan 1;11(1):107-12. Clin Cancer Res. 2005. PMID: 15671534 - Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Scheri RP, et al. Ann Surg Oncol. 2007 Oct;14(10):2861-6. doi: 10.1245/s10434-007-9472-y. Epub 2007 Jul 18. Ann Surg Oncol. 2007. PMID: 17882497 - Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
Abrahamsen HN, Sorensen BS, Nexo E, Hamilton-Dutoit SJ, Larsen J, Steiniche T. Abrahamsen HN, et al. Clin Cancer Res. 2005 Feb 15;11(4):1425-33. doi: 10.1158/1078-0432.CCR-04-1193. Clin Cancer Res. 2005. PMID: 15746042 - Detection of melanoma micrometastases in sentinel nodes - the cons.
de Wilt JH, van Akkooi AC, Verhoef C, Eggermont AM. de Wilt JH, et al. Surg Oncol. 2008 Sep;17(3):175-81. doi: 10.1016/j.suronc.2008.06.004. Epub 2008 Jul 9. Surg Oncol. 2008. PMID: 18617395 Review. - Clinically relevant information from sentinel lymph node biopsies of melanoma patients.
Wen DR, Cochran AJ, Huang RR, Itakura E, Binder S. Wen DR, et al. J Surg Oncol. 2011 Sep;104(4):369-78. doi: 10.1002/jso.21818. J Surg Oncol. 2011. PMID: 21858831 Review.
Cited by
- Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
Zhang ZG, Zhu HM, Hua HK. Zhang ZG, et al. Skin Res Technol. 2024 Mar;30(3):e13618. doi: 10.1111/srt.13618. Skin Res Technol. 2024. PMID: 38468436 Free PMC article. - Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis.
Suman S, Markovic SN. Suman S, et al. Trends Immunol. 2023 Sep;44(9):724-743. doi: 10.1016/j.it.2023.07.002. Epub 2023 Aug 10. Trends Immunol. 2023. PMID: 37573226 Free PMC article. Review. - Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis.
Benito-Martín A, Jasiulionis MG, García-Silva S. Benito-Martín A, et al. Front Cell Dev Biol. 2023 Jan 10;10:1061982. doi: 10.3389/fcell.2022.1061982. eCollection 2022. Front Cell Dev Biol. 2023. PMID: 36704194 Free PMC article. Review. - Tumor-draining lymph nodes: At the crossroads of metastasis and immunity.
du Bois H, Heim TA, Lund AW. du Bois H, et al. Sci Immunol. 2021 Sep 10;6(63):eabg3551. doi: 10.1126/sciimmunol.abg3551. Epub 2021 Sep 3. Sci Immunol. 2021. PMID: 34516744 Free PMC article. Review. - Melanoma Progression under Obesity: Focus on Adipokines.
Olszańska J, Pietraszek-Gremplewicz K, Nowak D. Olszańska J, et al. Cancers (Basel). 2021 May 10;13(9):2281. doi: 10.3390/cancers13092281. Cancers (Basel). 2021. PMID: 34068679 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous